Charles Weston
Stock Analyst at RBC Capital
(0.18)
# 4,200
Out of 4,334 analysts
324
Total ratings
35.6%
Success rate
-6.5%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | $18 | $16.90 | +6.51% | 6 | May 13, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | $32 | $26.50 | +20.75% | 1 | May 12, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | $670 | $492.80 | +35.96% | 36 | May 8, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | $220 | $234.50 | -6.18% | 21 | May 6, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | $210 | $173.10 | +21.32% | 20 | May 6, 2026 | |
| ETR: EVT Evotec SE | Maintained: Buy | $10 | $5.04 | +98.61% | 52 | May 4, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | $225 | $129.40 | +73.88% | 30 | Apr 15, 2026 | |
| SWX: PPGN PolyPeptide Group AG | Maintained: Buy | $44 | $38.30 | +14.88% | 7 | Apr 13, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Buy | $110 | $78.50 | +40.13% | 10 | Apr 8, 2026 | |
| LON: OXB Oxford Biomedica plc | Maintained: Buy | $1,170 | $618.00 | +89.32% | 27 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $96 | $80.25 | +19.63% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,900 | $1,199.00 | +58.47% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $480 → $4.8 | $388.00 | -98.76% | 21 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $62.84 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,600 | $485.00 | +229.90% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $94.60 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310 | $222.50 | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.15 → $215 | $197.00 | n/a | 14 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $3.15 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $287 | $34.42 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $67.10 | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.1 | $0.80 | n/a | 8 | Apr 24, 2018 |
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: $18
Current: $16.90
Upside: +6.51%
Carl Zeiss Meditec AG
May 12, 2026
Maintained: Hold
Price Target: $32
Current: $26.50
Upside: +20.75%
Lonza Group AG
May 8, 2026
Maintained: Buy
Price Target: $670
Current: $492.80
Upside: +35.96%
Sartorius Aktiengesellschaft
May 6, 2026
Maintained: Hold
Price Target: $220
Current: $234.50
Upside: -6.18%
Sartorius Stedim Biotech S.A.
May 6, 2026
Maintained: Buy
Price Target: $210
Current: $173.10
Upside: +21.32%
Evotec SE
May 4, 2026
Maintained: Buy
Price Target: $10
Current: $5.04
Upside: +98.61%
Oxford Nanopore Technologies plc
Apr 15, 2026
Reiterated: Buy
Price Target: $225
Current: $129.40
Upside: +73.88%
PolyPeptide Group AG
Apr 13, 2026
Maintained: Buy
Price Target: $44
Current: $38.30
Upside: +14.88%
Bachem Holding AG
Apr 8, 2026
Maintained: Buy
Price Target: $110
Current: $78.50
Upside: +40.13%
Oxford Biomedica plc
Mar 24, 2026
Maintained: Buy
Price Target: $1,170
Current: $618.00
Upside: +89.32%
Mar 16, 2026
Maintained: Hold
Price Target: $108 → $96
Current: $80.25
Upside: +19.63%
Mar 4, 2026
Maintained: Buy
Price Target: $1,900
Current: $1,199.00
Upside: +58.47%
Feb 24, 2026
Maintained: Buy
Price Target: $480 → $4.8
Current: $388.00
Upside: -98.76%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $62.84
Upside: -
Oct 2, 2025
Reiterated: Buy
Price Target: $1,600
Current: $485.00
Upside: +229.90%
Jan 7, 2025
Reiterated: Buy
Price Target: $250
Current: $94.60
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $310
Current: $222.50
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: $2.15 → $215
Current: $197.00
Upside: n/a
Jul 12, 2021
Maintained: Buy
Price Target: $26
Current: $3.15
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: $287
Current: $34.42
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $160
Current: $67.10
Upside: n/a
Apr 24, 2018
Maintained: Buy
Price Target: $6.1
Current: $0.80
Upside: n/a